26.4 C
New York
Saturday, June 13, 2026

Tag: injection

RUBELLITE ENERGY CORP. REPORTS RECORD PRODUCTION AND ADJUSTED FUNDS FLOW PER SHARE IN SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS

CALGARY, AB, Aug. 5, 2025 /CNW/ - (TSX: RBY) - Rubellite Energy Corp. ("Rubellite" or the "Company"), is pleased to report its second quarter...

Sunshine Lake Pharma Co., Ltd. (06887.HK) Completes Listing, Market Capitalisation Expected to Rapidly Surpass RMB 50 Billion

GUANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Sunshine Lake Pharma Co., Ltd. (06887.HK) announced that the company will officially list on the Hong Kong Stock...

CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them

Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells

World’s Largest Factory for Humanoid Robots, WorkFar now Offers Contract Manufacturing too

Robotics company WorkFar invites companies interested in reshoring their manufacturing operations to set up shop in its massive, US-based manufacturing footprint that boasts Industry...

Silicon Labs Extends IoT Security Leadership with World’s First PSA Level 4 Certification

Series 3 Secure Vault, debuting on the SiXG301 SoC in the next-gen Series 3 lineup, achieves highest security certification for advanced IoT protection AUSTIN, Texas,...

Grid8 Launches Free Interconnection Dashboard to Unlock Faster, Smarter Grid Access for Data Centers and Renewable Developers

PHOENIX, Aug. 4, 2025 /PRNewswire/ -- Grid8, a leader in AI-powered interconnection solutions, today announced the launch of its new Interconnection Dashboard, a free tool...

First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR

SHANGHAI, Aug. 3, 2025 /PRNewswire/ -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in...

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader

Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.

In response to the rise in injection attacks, technology company Facephi takes action to strengthen and secure digital identity processes

Facephi, a leading provider and developer in the identity verification sector, reinforces digital identity protection with its new feature, Advanced Injection Defense, designed to stop deepfakes and manipulated images and videos
Facephi, a leading provider and developer in the identity verification sector, reinforces digital identity protection with its new feature, Advanced Injection Defense, designed to stop deepfakes and manipulated images and videos

Energy Transition Meets Emerging Tech on August 20th at EnerCom’s 30th Anniversary Energy Investment Conference

Landmark 30th Anniversary EnerCom Denver – The Energy Investment Conference Announces Energy Transition and Emerging Technology Session Schedule Qualified Investors and Analysts Can Register at...

Eesti Energia Group Unaudited Results for Q2 2025

Sales Revenues and Profitability

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInjection